Pfizer

Stories 1 - 20 |  Next >>

Health Worker Accidentally Gets a 'Massive' Vaccine Dose

Italian woman is doing fine regardless

(Newser) - A 23-year-old Italian woman is doing well after she accidentally received six doses of the Pfizer-BioNTech COVID-19 vaccine on Sunday. A health worker at Noa hospital in Tuscany had filled a syringe with an entire vial of the vaccine, which is to be split into six doses. It was only...

FDA Approves 'Significant Step' Toward Ending Pandemic

Pfizer vaccine approved for 12 to 15-year-olds

(Newser) - The first coronavirus vaccine approved for adults and older teens in the US is now the first to gain approval for adolescents as well. The Food and Drug Administration announced Monday that the emergency use authorization for the Pfizer/BioNTech has been expanded to include people 12 to 15 years old....

Pfizer Vaccine for Ages 12 to 15 Expected Soon

FDA on track to give approval by early next week, but could come even sooner

(Newser) - The US Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement...

Millions Are Missing Their Second Dose of COVID Vaccine

Millions are skipping or late for their shot, putting immunity at risk

(Newser) - One is not enough if you’re talking about the Pfizer or Moderna COVID vaccine shots. But millions are skipping their second dose, the New York Times reports. Why? Hard to say for sure, but some people might be choosing to skip it because they feel they have enough protection...

Pfizer: Fake COVID Shots Held Anti-Wrinkle Treatment

Company says counterfeit vaccines have been detected in Mexico, Poland

(Newser) - The combination of people desperate for coronavirus vaccines and worldwide shortages has created an opportunity that criminals are eagerly exploiting, Pfizer warns. The company says it has tested vials seized by investigators in Mexico and Poland and confirmed that phony Pfizer vaccines were involved in both cases, the Wall Street ...

Israeli Study Has Bad News on 'Breakthrough' Infections

South African variant of COVID can break through Pfizer vaccine, it finds

(Newser) - An Israeli study has disheartening news, though researchers are cautioning that more study is needed: The South African coronavirus variant can "break through" and infect those who have received the Pfizer vaccine, the study of around 800 people found. Half of the subjects had tested positive for COVID-19 two...

Pfizer Asks OK for Younger Recipients

FDA approval probably is a few weeks away

(Newser) - Pfizer asked the Food and Drug Administration on Friday to add recipients ages 12 to 15 to the emergency use authorization for its coronavirus vaccine. At the moment, Pfizer has permission to distribute the vaccine for anyone 16 or older. The company said last week that its trials showed its...

Pfizer Vaccine Could Be Nearing 'Full Approval'

Latest data indicates 91.3% efficacy for 6 months

(Newser) - The coronavirus vaccine from Pfizer and BioNTech maintains 91.3% efficacy for at least six months after the second dose, even against the worrisome B.1.351 variant first identified in South Africa, the companies said Thursday. The findings—which double the previous best estimate of 90 days of protection,...

For Younger Teens, This COVID Vaccine Is Looking Good

Pfizer says its vaccine has been shown to be safe, very protective in kids as young as 12

(Newser) - Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in the fall. Most COVID-19 vaccines being rolled out are for adults, at higher risk from...

After Detroit Spurns Vaccine, Experts Warn on 'Brand Shopping'

Mayor Duggan turned down 6.2K J&J doses, saying he wants Pfizer, Moderna for city

(Newser) - Johnson and Johnson's newly approved coronavirus vaccine doesn't have to be kept in the same ultra-cold temps as the Pfizer and Moderna versions, and patients need only one shot, as opposed to the double dose required by the other companies. But this week, the city of Detroit declined...

Pfizer Is Testing 2 Ways to Fight COVID Variants

'Every year, you need to go to get your flu vaccine. It's going to be the same with COVID'

(Newser) - Unless COVID-19 is eradicated, the fight to develop vaccines might go on indefinitely. Pfizer says it is looking into two separate ways to provide protection against new and more infectious COVID variants, especially the one first detected in South Africa, CNBC reports. Board member Dr. Scott Gottlieb says the company...

FDA Drops Ultra-Cold Storage Rule for Pfizer Vaccine

Allowing regular freezer temperatures should simplify distribution

(Newser) - The Food and Drug Administration made distribution of the Pfizer coronavirus vaccine easier on Thursday by decreeing it can be stored in regular freezer temperatures after all. The agency had required the vaccine be kept at minus 76 degrees Fahrenheit to minus 112 degrees, the Hill reports. That was a...

2 Big Finds on the Pfizer Vaccine Front

One dose is effective, and the vaccine can be stored in ordinary freezers

(Newser) - A new study has produced two big finds that could have wide-ranging implications for coronavirus vaccine distribution and storage. Per the Wall Street Journal , the peer-reviewed research out of Israel published Thursday in the Lancet shows that just one shot of the Pfizer-BioNTech vaccine is 85% effective at stopping symptomatic...

Study: 2 Shots of Pfizer Are 'Incredibly Effective'

But health officials report worrisome numbers on South Africa variant

(Newser) - Israel, which got off to a quick start in vaccinating its citizens, has now seen the benefits documented. Among 600,000 people who received both doses of the Pfizer vaccine, symptomatic cases have dropped 94%, a study shows. And that group was 92% less likely to develop severe COVID-19 illness,...

South Korea Has New Accusation Against North Korea

It says its neighbor tried to hack Pfizer; no word on whether the attack was successful

(Newser) - The North Korean regime tried to hack US drugmaker Pfizer in an effort to steal information on the company's coronavirus vaccine, according to South Korea's National Intelligence Service. Lawmakers were briefed on the findings during a closed-door session of the National Assembly's intelligence committee on Tuesday, per...

Vaccine Brand Is Tough Sell in Europe

Experts say comparisons of the products' efficacy can be misleading

(Newser) - Many Europeans are desperate for a coronavirus vaccine. But not just any vaccine. As AstraZeneca shots are rolling out to European Union nations this month, joining the Pfizer and Moderna doses already available, some people are balking at being offered a vaccine that they perceive—fairly or not—as second-best....

Mixing Vaccines Could Provide 'Better Antibody Response'
New Study Looks
at Mixing Vaccines

New Study Looks at Mixing Vaccines

Human trial will attempt to replicate results found in mice

(Newser) - There have been limited cases of people receiving one coronavirus vaccine for their first dose, and a different vaccine for their second. So how will that affect their immunity? That's now the subject of a trial in the UK, seeking to discover whether a mix of vaccines proves effective...

In Moderna's Good News, One 'Ominous' Finding
In Moderna's Good News,
One 'Ominous' Finding
IN CASE YOU MISSED IT

In Moderna's Good News, One 'Ominous' Finding

Vaccine appears to work against new variants, but it's less effective on South African version

(Newser) - Moderna reported mostly good news on Monday about two new variants of the coronavirus, though the Washington Post sees an "ominous" red flag in the mix. In the undisputed good news, the company says preliminary studies suggest its COVID vaccine provides protection against fast-spreading variants of the virus first...

Different Vaccine Is Making Headlines, This One for MS

BioNTech vaccine reduces severity of symptoms and delays progression, study suggests

(Newser) - BioNTech has a second vaccine making headlines, but this one has nothing to do with COVID. Instead, it shows promise against multiple sclerosis. In a study at Science , researchers say the vaccine reduced the severity of symptoms in lab mice, delayed the disease's progression in mice with early signs...

Iran: Vaccine From US, Britain Can't Be Trusted

With more than 1.3M infections, nation already is struggling to contain outbreak

(Newser) - Calling them "completely untrustworthy," Iran has prohibited importing coronavirus vaccines produced by the US or Britain. Ayatollah Ali Khamenei made the announcement Friday in a televised address, the Guardian reports. "It's not unlikely they would want to contaminate other nations," he said. Mentioning the Pfizer...

Stories 1 - 20 |  Next >>
Popular on Newser
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.